1409 related items for PubMed ID: 32480366
1. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T, Rutkowski MJ, Micko A, Shiroishi M, Jason Liu CS, Wrobel B, Carmichael J, Zada G.
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[Abstract] [Full Text] [Related]
2. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly.
Cardinal T, Collet C, Wedemeyer M, Singer PA, Weiss M, Zada G, Carmichael JD.
Front Endocrinol (Lausanne); 2021 Jun; 12():743052. PubMed ID: 34867787
[Abstract] [Full Text] [Related]
3. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Hofstetter CP, Mannaa RH, Mubita L, Anand VK, Kennedy JW, Dehdashti AR, Schwartz TH.
Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
[Abstract] [Full Text] [Related]
4. Endoscopic Transsphenoidal Approach for Acromegaly with Remission Rates in 401 Patients: 2010 Consensus Criteria.
Anik I, Cabuk B, Gokbel A, Selek A, Cetinarslan B, Anik Y, Ceylan S.
World Neurosurg; 2017 Dec; 108():278-290. PubMed ID: 28887283
[Abstract] [Full Text] [Related]
5. Outcomes after a purely endoscopic transsphenoidal resection of growth hormone-secreting pituitary adenomas.
Campbell PG, Kenning E, Andrews DW, Yadla S, Rosen M, Evans JJ.
Neurosurg Focus; 2010 Oct; 29(4):E5. PubMed ID: 20887130
[Abstract] [Full Text] [Related]
6. Endoscopic Endonasal Approach to the Growth Hormone-Secreting Pituitary Adenomas: Endocrinologic Outcome in 68 Patients.
Taghvaei M, Sadrehosseini SM, Ardakani JB, Nakhjavani M, Zeinalizadeh M.
World Neurosurg; 2018 Sep; 117():e259-e268. PubMed ID: 29902603
[Abstract] [Full Text] [Related]
7. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M, Ferraz T.
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[Abstract] [Full Text] [Related]
8. A follow-up study on outcomes of endoscopic transsphenoidal approach for acromegaly.
Aydin S, Ozoner B, Sahin S, Alizada O, Comunoglu N, Oz B, Gazioglu N, Kadioglu P, Tanriover N.
Clin Neurol Neurosurg; 2020 Nov; 198():106201. PubMed ID: 32927330
[Abstract] [Full Text] [Related]
9. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature.
Almeida JP, Ruiz-Treviño AS, Liang B, Omay SB, Shetty SR, Chen YN, Anand VK, Grover K, Christos P, Schwartz TH.
J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548
[Abstract] [Full Text] [Related]
10. Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission.
Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA.
J Clin Endocrinol Metab; 2013 Aug; 98(8):3190-8. PubMed ID: 23737543
[Abstract] [Full Text] [Related]
11. Final Outcome in Growth Hormone-Secreting Adenomas After Combination of Maximal Tumor Resection and Medical Treatment.
Torres A, Sanmillan JL, Lau R, Gabarros A.
World Neurosurg; 2021 Oct; 154():e292-e301. PubMed ID: 34252630
[Abstract] [Full Text] [Related]
12. Prognostic Factors of Acromegalic Patients with Growth Hormone-Secreting Pituitary Adenoma After Transsphenoidal Surgery.
Taweesomboonyat C, Oearsakul T.
World Neurosurg; 2021 Feb; 146():e1360-e1366. PubMed ID: 33309643
[Abstract] [Full Text] [Related]
13. Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas.
Negm HM, Al-Mahfoudh R, Pai M, Singh H, Cohen S, Dhandapani S, Anand VK, Schwartz TH.
J Neurosurg; 2017 Aug; 127(2):397-408. PubMed ID: 27791524
[Abstract] [Full Text] [Related]
14. Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission.
Wang YY, Higham C, Kearney T, Davis JR, Trainer P, Gnanalingham KK.
Clin Endocrinol (Oxf); 2012 Mar; 76(3):399-406. PubMed ID: 21824170
[Abstract] [Full Text] [Related]
15. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S, Fukuhara N, Horiguchi K, Yamaguchi-Okada M, Nishioka H, Takeshita A, Takeuchi Y, Ito J, Inoshita N.
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[Abstract] [Full Text] [Related]
16. A single-center experience of transsphenoidal endoscopic surgery for acromegaly in 73 patients: results and predictive factors for remission.
Unal TC, Aydoseli A, Ozgen U, Dolas I, Sabanci PA, Aras Y, Ozturk M, Ozata MS, Gul N, Kubat Uzum A, Mutlu U, Bilgic B, Saka E, Yarman S, Sencer A.
Br J Neurosurg; 2024 Jun; 38(3):648-653. PubMed ID: 34241568
[Abstract] [Full Text] [Related]
17. Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas.
Hofstetter CP, Shin BJ, Mubita L, Huang C, Anand VK, Boockvar JA, Schwartz TH.
Neurosurg Focus; 2011 Apr; 30(4):E10. PubMed ID: 21456921
[Abstract] [Full Text] [Related]
18. Transsphenoidal surgery for acromegaly: predicting remission with early postoperative growth hormone assays.
Sarkar S, Jacob KS, Pratheesh R, Chacko AG.
Acta Neurochir (Wien); 2014 Jul; 156(7):1379-87; discussion 1387. PubMed ID: 24781680
[Abstract] [Full Text] [Related]
19. Endocrinological outcomes following endoscopic and microscopic transsphenoidal surgery in 113 patients with acromegaly.
Sarkar S, Rajaratnam S, Chacko G, Chacko AG.
Clin Neurol Neurosurg; 2014 Nov; 126():190-5. PubMed ID: 25278017
[Abstract] [Full Text] [Related]
20. Revisiting the Role of Insulin-like Growth Factor-1 Measurement After Surgical Treatment of Acromegaly.
Jung IH, Choi S, Ku CR, Lee SG, Lee EJ, Kim SH, Kim EH.
J Clin Endocrinol Metab; 2021 Jun 16; 106(7):e2589-e2599. PubMed ID: 33738470
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
